UBS Group »

Processa Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Processa Pharmaceuticals (PCSA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Processa Pharmaceuticals

May 2024Jul 2024Sep 2024Nov 2024Jan 202502k4k6k8k10k02000400060008000
Value ($)Share countHistorical PCSA position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Processa Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Processa Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $7.1k 7.9k 0.89
2024-09-30 $713 521 1.37
2024-03-31 $9.9k 4.2k 2.37

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Processa Pharmaceuticals

Hrt Financial
Vanguard Group
Geode Capital Management
Miracle Mile Advisors
UBS Group
Tower Research Capital
Wells Fargo & Company
Bank of America Corporation

View all funds holding Processa Pharmaceuticals